SLC16A1 and neoplasm: Causes intracellular lactate accumulation, leading to feedback inhibition of glycolysis and alteration of the tumor microenvironment. Authors’ insight: Complementary to LDHA inhibitors, it represents another key regulatory node in the lactylation pathway and may be particularly effective in tumors with high SLC16A1 expression.